This test takes a multi-target approach and screens for altered DNA, hemoglobin biomarkers, methylation of genes (NDRG4 and BMP3), and KRAS point mutations for early detection of CRC [33]. The gene discussed is KRAS; the disease is colorectal carcinoma.